Zobrazeno 1 - 10
of 170
pro vyhledávání: '"Terri Levien"'
Autor:
Terri Levien, Danial E. Baker
Publikováno v:
Hospital Pharmacy. 57:615-621
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also r
Autor:
Juliana K Beauchene, Terri Levien
Publikováno v:
J Pharm Technol
Objective: To review the efficacy and safety of the newly Food and Drug Administration approved drug lasmiditan, and its place in therapy in the treatment of acute migraine attacks. Data Sources: A literature search of Web of Science, PubMed, and Goo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07565d58edd9d9fc766ec8ed6298a4b9
https://europepmc.org/articles/PMC8404748/
https://europepmc.org/articles/PMC8404748/
Publikováno v:
The Senior care pharmacist. 35(4)
The prevalence and clinical impact of diabetes mellitus (DM) continues to increase in the United States and throughout the world. Older adults are at increased risk for adverse outcomes associated with hypoglycemia, particularly in situations where a
Autor:
Danial E. Baker, Terri Levien
Publikováno v:
Hospital Pharmacy. 54:12-19
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also r
Publikováno v:
Hospital Pharmacy. 53:136-141
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also r
Publikováno v:
Hospital Pharmacy. :001857872110295
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy and Therapeutics Committees. Subscribers also
Publikováno v:
The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists. 33(4)
Objective To provide a review of tardive dyskinesia (TD) symptoms, etiology, pathophysiology, and treatments. Data sources PubMed, Web of Science, ClinicalTrials. gov, and Google Scholar were searched for relevant literature using a combination of th
Publikováno v:
Hospital Pharmacy. 51:71-82
Each month, subscribers to The Formulary Monograph Service receive five to six well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to your Pharmacy and Therapeutics Committee. Subscri
Publikováno v:
Hospital Pharmacy. 50:396-415
*Founder and Contributing Editor, The Formulary; †Drug Information Intern, College of Pharmacy, Washington State University Spokane; ‡Clinical Professor, College of Pharmacy, Washington State University; §Director, Drug Information Center, and P
Publikováno v:
Hospital Pharmacy. 50:059-071